NEW YORK, Aug. 1 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today listed the common stock of Cardium Therapeutics, Inc. under the ticker symbol CXM. Cardium Therapeutics, Inc. is a medical technology company primarily focused on the development, manufacture and sale of innovative products for cardiovascular and related indications. "We proudly welcome Cardium Therapeutics, Inc. to the American Stock Exchange," said John McGonegal, Senior Vice President of Amex Equities Group. "Many new medical technology companies have chosen to list at the Amex, and we are pleased that Cardium Therapeutics is the latest company to recognize our expanding presence in this important sector." The specialist in Cardium Therapeutics, Inc. will be HBH Specialists LLC. For further information on CXM and other Amex-listed companies, please visit http://www.amex.com/. About American Stock Exchange The American Stock Exchange(R) (Amex(R)) offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 336 ETFs to date. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit http://www.amex.com/ DATASOURCE: American Stock Exchange CONTACT: Catherine Chantharaj of American Stock Exchange, +1-212-306-1689, Web site: http://www.amex.com/

Copyright